Clinical trial
Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD
NCT03803124 is registered in ClinicalTrials.gov with Regional Hospital Holstebro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD
- Lead sponsor
- Regional Hospital Holstebro
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 15, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.